Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Adding a second method to PROTACs could improve cancer treatment.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

mTOR inhibitors may help treat lung fibrosis.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

A man's hair loss was linked to his HIV medication, which improved after changing drugs.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Baricitinib may effectively treat sudden hair whitening and regrowth in some cases.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Bortezomib chemotherapy can cause temporary skin rashes.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.